New Zealand markets closed

Rennova Health, Inc. (RNVA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 01:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0000
Open0.0001
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0001
52-week range0.0000 - 0.0002
Volume29,864,158
Avg. volume56,426,026
Market cap40,551
Beta (5Y monthly)N/A
PE ratio (TTM)0.00
EPS (TTM)0.0500
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES

    WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be extended from M

  • GlobeNewswire

    RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS

    WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders. Dear Fellow Shareholders, As we begin 2024, I want to provide an update on some of our recent accomplishments and outline our plans for the future. Our efforts in recent years to build and sustain a viable business model for our healthcare services operations have gained momentum. 2023 was a significant year for the Compan

  • GlobeNewswire

    INNOVAQOR, INC. CEO PROVIDES YEAR END MESSAGE TO SHAREHOLDERS

    WEST PALM BEACH, Fla., Dec. 20, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR) Chief Executive Officer, Darrell Peterson provides the following year end message to shareholders. Dear Fellow Shareholders As we approach the end of 2023 I want to share my optimism about what has been accomplished in 2023 and the strategy and path we have adopted for the coming year. We remain confident that software and IT solutions for the healthcare sector provides unlimited opportunity for growth and value